{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:35:33Z","timestamp":1774305333571,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pbio.3001221","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000}}],"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["ERT-3867"],"award-info":[{"award-number":["ERT-3867"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosbiology.org"],"crossmark-restriction":false},"short-container-title":["PLoS Biol"],"abstract":"<jats:p>Premature termination codons (PTC) cause over 10% of genetic disease cases. Some aminoglycosides that bind to the ribosome decoding center can induce PTC readthrough and restore low levels of full-length functional proteins. However, concomitant inhibition of protein synthesis limits the extent of PTC readthrough that can be achieved by aminoglycosides like G418. Using a cell-based screen, we identified a small molecule, the phenylpyrazoleanilide Y-320, that potently enhances<jats:italic>TP53<\/jats:italic>,<jats:italic>DMD<\/jats:italic>, and C<jats:italic>OL17A1<\/jats:italic>PTC readthrough by G418. Unexpectedly, Y-320 increased cellular protein levels and protein synthesis, measured by SYPRO Ruby protein staining and puromycin labeling, as well as ribosome biogenesis measured using antibodies to rRNA and ribosomal protein S6. Y-320 did not increase the rate of translation elongation and it exerted its effects independently of mTOR signaling. At the single cell level, exposure to Y-320 and G418 increased ribosome content and protein synthesis which correlated strongly with PTC readthrough. As a single agent, Y-320 did not affect translation fidelity measured using a luciferase reporter gene but it enhanced misincorporation by G418. RNA-seq data showed that Y-320 up-regulated the expression of CXC chemokines CXCL10, CXCL8, CXCL2, CXCL11, CXCL3, CXCL1, and CXCL16. Several of these chemokines exert their cellular effects through the receptor CXCR2 and the CXCR2 antagonist SB225002 reduced cellular protein levels and PTC readthrough in cells exposed to Y-320 and G418. These data show that the self-limiting nature of PTC readthrough by G418 can be compensated by Y-320, a potent enhancer of PTC readthrough that increases ribosome biogenesis and protein synthesis. They also support a model whereby increased PTC readthrough is enabled by increased protein synthesis mediated by an autocrine chemokine signaling pathway. The findings also raise the possibility that inflammatory processes affect cellular propensity to readthrough agents and that immunomodulatory drugs like Y-320 might find application in PTC readthrough therapy.<\/jats:p>","DOI":"10.1371\/journal.pbio.3001221","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T18:00:31Z","timestamp":1620064831000},"page":"e3001221","update-policy":"https:\/\/doi.org\/10.1371\/journal.pbio.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough"],"prefix":"10.1371","volume":"19","author":[{"given":"Sara","family":"Hosseini-Farahabadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Baradaran-Heravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5132-2101","authenticated-orcid":true,"given":"Carla","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Flibotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-0793","authenticated-orcid":true,"given":"Michel","family":"Roberge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"issue":"8","key":"pbio.3001221.ref001","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/humu.20763","article-title":"A meta-analysis of nonsense mutations causing human genetic disease","volume":"29","author":"M Mort","year":"2008","journal-title":"Hum Mutat"},{"issue":"1","key":"pbio.3001221.ref002","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","article-title":"Therapeutics Based on Stop Codon Readthrough.","volume":"15","author":"KM Keeling","year":"2014","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"7140","key":"pbio.3001221.ref003","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"EM Welch","year":"2007","journal-title":"Nature"},{"key":"pbio.3001221.ref004","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-med-120611-144851","article-title":"Ataluren as an Agent for Therapeutic Nonsense Suppression.","volume":"64","author":"SW Peltz","year":"2013","journal-title":"Annu Rev Med."},{"issue":"4","key":"pbio.3001221.ref005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nm0496-467","article-title":"Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations","volume":"2","author":"M Howard","year":"1996","journal-title":"Nat Med"},{"issue":"5692","key":"pbio.3001221.ref006","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/277146a0","article-title":"Phenotypic suppression and misreading in Saccharomyces cerevisiae","volume":"277","author":"A Singh","year":"1979","journal-title":"Nature"},{"issue":"5692","key":"pbio.3001221.ref007","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/277148a0","article-title":"Phenotypic suppression of nonsense mutants in yeast by aminoglycoside antibiotics","volume":"277","author":"E Palmer","year":"1979","journal-title":"Nature"},{"issue":"17","key":"pbio.3001221.ref008","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/nar\/13.17.6265","article-title":"Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside anthiotics G-418 and paromomycin","volume":"13","author":"JF Burke","year":"1985","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"pbio.3001221.ref009","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/nar\/gkq1277","article-title":"Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides","volume":"39","author":"C Floquet","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"pbio.3001221.ref010","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1093\/nar\/gki862","article-title":"Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: Role of the number of rings and positive charges in the specific binding leading to miscoding","volume":"33","author":"B Fran\u00e7ois","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"51","key":"pbio.3001221.ref011","doi-asserted-by":"crossref","first-page":"E10899","DOI":"10.1073\/pnas.1715501114","article-title":"Aminoglycoside interactions and impacts on the eukaryotic ribosome","volume":"114","author":"I Prokhorova","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"52","key":"pbio.3001221.ref012","doi-asserted-by":"crossref","first-page":"20888","DOI":"10.1073\/pnas.0811258106","article-title":"Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity","volume":"105","author":"SN Hobbie","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pbio.3001221.ref013","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/embo-reports\/kve062","article-title":"Structural basis for selectivity and toxicity of ribosomal antibiotics","volume":"2","author":"EC B\u00f6ttger","year":"2001","journal-title":"EMBO Rep"},{"issue":"23","key":"pbio.3001221.ref014","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1021\/jm3012992","article-title":"Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: A strategy for treatment of genetic diseases caused by nonsense mutations","volume":"55","author":"J Kandasamy","year":"2012","journal-title":"J Med Chem"},{"issue":"4","key":"pbio.3001221.ref015","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1074\/jbc.M113.533588","article-title":"Designer aminoglycosides that selectively inhibit cytoplasmic rather than mitochondrial ribosomes show decreased ototoxicity a strategy for the treatment of genetic diseases","volume":"289","author":"E Shulman","year":"2014","journal-title":"J Biol Chem"},{"issue":"14","key":"pbio.3001221.ref016","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1093\/nar\/gkw638","article-title":"Novel small molecules potentiate premature termination codon readthrough by aminoglycosides","volume":"44","author":"A Baradaran-Heravi","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"pbio.3001221.ref017","doi-asserted-by":"crossref","first-page":"e0216423","DOI":"10.1371\/journal.pone.0216423","article-title":"The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418.","volume":"14","author":"MW Ferguson","year":"2019","journal-title":"PLoS ONE"},{"issue":"5","key":"pbio.3001221.ref018","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/acsmedchemlett.8b00610","article-title":"2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides","volume":"10","author":"SM Rabea","year":"2019","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"pbio.3001221.ref019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13024-020-00369-5","article-title":"Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency.","volume":"15","author":"J Frew","year":"2020","journal-title":"Mol Neurodegener."},{"issue":"1","key":"pbio.3001221.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph7010001","article-title":"A new phenylpyrazoleanilide, Y-320, inhibits interleukin 17 production and ameliorates collagen-induced arthritis in mice and cynomolgus monkeys.","volume":"7","author":"H Ushio","year":"2014","journal-title":"Pharmaceuticals."},{"issue":"11","key":"pbio.3001221.ref021","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1158\/0008-5472.CAN-13-2235","article-title":"Identification and characterization of small molecules that inhibit nonsense mediated RNA decay and suppress nonsense p53 mutations","volume":"74","author":"L Martin","year":"2015","journal-title":"Cancer Res"},{"issue":"58","key":"pbio.3001221.ref022","first-page":"1","article-title":"Rescue of nonsense mutations by amlexanox in human cells.","volume":"7","author":"S Gonzalez-Hilarion","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"pbio.3001221.ref023","doi-asserted-by":"crossref","first-page":"jcs214346","DOI":"10.1242\/jcs.214346","article-title":"SunRiSE\u2014measuring translation elongation at single-cell resolution by means of flow cytometry","volume":"131","author":"RJ Arg\u00fcello","year":"2018","journal-title":"J Cell Sci"},{"issue":"1","key":"pbio.3001221.ref024","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2049-3002-1-20","article-title":"The metabolic demands of cancer cells are coupled to their size and protein synthesis rates","volume":"1","author":"SC Dolfi","year":"2013","journal-title":"Cancer Metab"},{"issue":"1","key":"pbio.3001221.ref025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome Biogenesis in Cancer: New Players and Therapeutic Avenues.","volume":"18","author":"J Pelletier","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"pbio.3001221.ref026","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1042\/BST20110682","article-title":"Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis","volume":"40","author":"V Iadevaia","year":"2012","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"pbio.3001221.ref027","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1152\/physiol.00024.2006","article-title":"The mTOR pathway in the control of protein synthesis.","volume":"21","author":"X Wang","year":"2006","journal-title":"Physiol"},{"issue":"21","key":"pbio.3001221.ref028","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.","volume":"99","author":"AR Tee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"pbio.3001221.ref029","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"H Zhang","year":"2003","journal-title":"J Clin Invest"},{"issue":"16","key":"pbio.3001221.ref030","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"N Hay","year":"2004","journal-title":"Genes Dev"},{"issue":"1","key":"pbio.3001221.ref031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2001-1326-1-29","article-title":"mTOR: a serendipitous discovery and implications for breast cancer","volume":"1","author":"SB Rapamycin","year":"2012","journal-title":"Clin Transl Med"},{"issue":"45","key":"pbio.3001221.ref032","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"AY Choo","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"43","key":"pbio.3001221.ref033","doi-asserted-by":"crossref","first-page":"17350","DOI":"10.1073\/pnas.1313473110","article-title":"Naked mole-rat has increased translational fidelity compared with the mouse, as well as a unique 28S ribosomal RNA cleavage","volume":"110","author":"J Azpurua","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pbio.3001221.ref034","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/157018008784619861","article-title":"Phenylpyazoleanilides as Potent Inhibitor of IL-15 Dependent T Cell Proliferation. Part 2: Discovery of a New Drug Candidate, Y-320.","volume":"5","author":"H Ushio","year":"2008","journal-title":"Lett Drug Des Discov"},{"issue":"2","key":"pbio.3001221.ref035","first-page":"95","article-title":"Chemokines and chemokine receptors: their manifold roles in homeostasis and disease","volume":"1","author":"Y Le","year":"2004","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"pbio.3001221.ref036","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00384-010-0901-1","article-title":"Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival","volume":"25","author":"D Doll","year":"2010","journal-title":"Int J Color Dis"},{"key":"pbio.3001221.ref037","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014a Target for Novel Cancer Therapy","volume":"63","author":"R Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"pbio.3001221.ref038","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2217\/14796694.1.5.699","article-title":"Mitogenic effects of interleukin-8\/CXCL8 on cancer cells","volume":"1","author":"YM Zhu","year":"2005","journal-title":"Future Oncol"},{"issue":"2","key":"pbio.3001221.ref039","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/ijms18020342","article-title":"Mechanisms of regulation of the chemokine-receptor network.","volume":"18","author":"MJ Stone","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pbio.3001221.ref040","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1189\/jlb.0408231","article-title":"The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice","volume":"84","author":"AF Bento","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"17","key":"pbio.3001221.ref041","doi-asserted-by":"crossref","first-page":"10095","DOI":"10.1074\/jbc.273.17.10095","article-title":"Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration","volume":"273","author":"JR White","year":"1998","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"pbio.3001221.ref042","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2008.04.015","article-title":"Aminoglycoside induced ototoxicity","volume":"249","author":"OW Guthrie","year":"2008","journal-title":"Toxicology"},{"issue":"6","key":"pbio.3001221.ref043","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0897190014546836","article-title":"Aminoglycoside-induced nephrotoxicity.","volume":"27","author":"KA Wargo","year":"2014","journal-title":"J Pharm Pract"},{"issue":"13","key":"pbio.3001221.ref044","doi-asserted-by":"crossref","first-page":"127218","DOI":"10.1016\/j.bmcl.2020.127218","article-title":"The relationship between the structure and toxicity of aminoglycoside antibiotics","volume":"30","author":"M Jospe-Kaufman","year":"2020","journal-title":"Bioorganic Med Chem Lett"},{"issue":"1\u20132","key":"pbio.3001221.ref045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-8993(97)00977-3","article-title":"Lysosomal targeting and accumulation of aminoglycoside antibiotics in sensory hair cells","volume":"777","author":"E Hashino","year":"1997","journal-title":"Brain Res"},{"issue":"7","key":"pbio.3001221.ref046","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1469-0691.2000.00105.x","article-title":"Does once-daily dosing prevent nephrotoxicity in all aminoglycosides equally?","volume":"6","author":"G Beaucaire","year":"2000","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"pbio.3001221.ref047","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1073\/pnas.79.5.1663","article-title":"Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: Possible mechanism of aminoglycoside toxicity","volume":"79","author":"KY Hostetler","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"pbio.3001221.ref048","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/sj.onc.1207396","article-title":"Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes","volume":"23","author":"A Willis","year":"2004","journal-title":"Oncogene"},{"issue":"10","key":"pbio.3001221.ref049","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutants gain new powers: News from the mutant p53 field","volume":"9","author":"R Brosh","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"pbio.3001221.ref050","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1073\/pnas.75.4.1759","article-title":"Two out of three: An alternative method for codon reading","volume":"75","author":"U Lagerkvist","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pbio.3001221.ref051","first-page":"2635","article-title":"Codon Reading and Translational Error.","volume":"256","author":"F Lustig","year":"1981","journal-title":"Nature"},{"issue":"2","key":"pbio.3001221.ref052","first-page":"551","article-title":"320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy","volume":"12","author":"J Hong","year":"2020","journal-title":"Am J Transl Res"},{"issue":"2","key":"pbio.3001221.ref053","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"S Van Linthout","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"6","key":"pbio.3001221.ref054","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1067\/mai.2003.1594","article-title":"Chemokines: Roles in leukocyte development, trafficking, and effector function","volume":"111","author":"SJ Ono","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"pbio.3001221.ref055","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-14-0160","article-title":"Chemokines in cancer","volume":"2","author":"MT Chow","year":"2014","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"pbio.3001221.ref056","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.0310182","article-title":"Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy","volume":"89","author":"P Mishra","year":"2011","journal-title":"J Leukoc Biol"},{"issue":"24","key":"pbio.3001221.ref057","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1128\/MCB.01237-08","article-title":"Coordinated Changes in mRNA Turnover, Translation, and RNA Processing Bodies in Bronchial Epithelial Cells following Inflammatory Stimulation","volume":"28","author":"Y Zhai","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"8","key":"pbio.3001221.ref058","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1172\/JCI92707","article-title":"Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients","volume":"127","author":"DT Woodley","year":"2017","journal-title":"J Clin Invest"},{"issue":"10","key":"pbio.3001221.ref059","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/mt.2014.140","article-title":"Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: Therapeutic implications for dystrophic epidermolysis bullosa","volume":"22","author":"J Cogan","year":"2014","journal-title":"Mol Ther"},{"issue":"21","key":"pbio.3001221.ref060","doi-asserted-by":"crossref","first-page":"17914","DOI":"10.1074\/jbc.M100728200","article-title":"Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine","volume":"276","author":"D Curman","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"pbio.3001221.ref061","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/nar\/gky1135","article-title":"Retrograde BMP signaling activates neuronal gene expression through widespread deployment of a conserved BMP-responsive cis-regulatory activation element","volume":"47","author":"R Vuilleumier","year":"2019","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1371\/journal.pbio.3001221","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000}}],"container-title":["PLOS Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3001221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:05:45Z","timestamp":1698991545000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3001221"}},"subtitle":[],"editor":[{"given":"Chaitan","family":"Khosla","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pbio.3001221","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pbio.3001221","asserted-by":"object"}]},"ISSN":["1545-7885"],"issn-type":[{"value":"1545-7885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]}}}